4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
Clinical trial NCT02721433 · COMPLETED
Trial details
- NCT number
- NCT02721433
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-09-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.